Cytokines in immune-mediated inflammatory myopathies: cellular sources, multiple actions and therapeutic implications.
about
Immunotherapies for Immune-Mediated Myopathies: A Current PerspectiveRefractory polymyositis undergoing remission following antitubercular therapyAdenosine signaling and the energetic costs of induced immunity.Increased Expression of the NOD-like Receptor Family, Pyrin Domain Containing 3 Inflammasome in Dermatomyositis and Polymyositis is a Potential Contributor to Their Pathogenesis.Long-term exposure to Myozyme results in a decrease of anti-drug antibodies in late-onset Pompe disease patients.Restoration of pharyngeal dilator muscle force in dystrophin-deficient (mdx) mice following co-treatment with neutralizing interleukin-6 receptor antibodies and urocortin 2.The Immune Response and the Pathogenesis of Idiopathic Inflammatory Myositis: a Critical Review.Three cases of anti-TNF induced myositis and literature review.Toll-Like Receptor 4-Myeloid Differentiation Primary Response Gene 88 Pathway Is Involved in the Inflammatory Development of Polymyositis by Mediating Interferon-γ and Interleukin-17A in Humans and Experimental Autoimmune Myositis Mouse Model.Quantitative T cell subsets profile in peripheral blood from patients with idiopathic inflammatory myopathies: tilting the balance towards proinflammatory and pro-apoptotic subsets.Inflammatory predisposition predicts disease phenotypes in muscular dystrophy.Quinacrine Suppresses Tumor Necrosis Factor-α and IFN-α in Dermatomyositis and Cutaneous Lupus Erythematosus.Interleukin-37: A crucial cytokine with multiple roles in disease and potentially clinical therapy.Targeted lipidomics analysis identified altered serum lipid profiles in patients with polymyositis and dermatomyositis.Current Classification and Management of Inflammatory Myopathies.Activated dendritic cells modulate proliferation and differentiation of human myoblasts.Clinical and multi-omics cross-phenotyping of patients with autoimmune and autoinflammatory diseases: the observational TRANSIMMUNOM protocol
P2860
Q30699742-AE6B0C8E-325F-4AC7-8162-DE2371784775Q35572640-0E1D46B9-9746-4A41-ACD3-E8D2C810AF83Q35615223-8FFC5D8B-3A18-4F61-90D3-96DD70448E70Q36856554-4FF47590-583C-4F76-BBF2-7464A11E18A8Q37394520-EF75618E-4B70-4E71-B0D3-778282237F03Q38700281-510F9AD6-B2DB-401B-BA45-DE4F23FF2C31Q38700961-64D948E4-1F99-4EFA-928C-8B76530B466BQ38785400-78CEB7CB-0748-4745-93C9-B91F14B1C18CQ42292003-A8C640F1-F41C-4D95-A126-82C214929C12Q46730821-293BCF61-04DF-420C-9563-13280504521AQ47153445-2D281837-6968-4913-B0F6-8FBDEDA45E0DQ47760514-735918F2-6D0E-41EA-BDDE-4284BE4884E4Q52649775-229DC3DF-94CB-41BF-9DD4-0DBB0D49FDD8Q54112905-A22AB2EB-92C0-40A9-872C-FA9EB2F54EECQ54977148-5E1015BC-3D49-444B-9952-11903F369653Q55013545-9FE6EE29-052B-4F8D-B7DD-2F9C21863724Q56517416-78F03728-B402-4F40-AA71-DAEB96C4159F
P2860
Cytokines in immune-mediated inflammatory myopathies: cellular sources, multiple actions and therapeutic implications.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Cytokines in immune-mediated i ...... and therapeutic implications.
@en
type
label
Cytokines in immune-mediated i ...... and therapeutic implications.
@en
prefLabel
Cytokines in immune-mediated i ...... and therapeutic implications.
@en
P2860
P356
P1476
Cytokines in immune-mediated i ...... s and therapeutic implications
@en
P2093
F L Mastaglia
P2860
P304
P356
10.1111/CEI.12445
P577
2014-12-01T00:00:00Z